The redistribution of body fat is a prevalent feature of the aging process [1, 2] . With aging, body fat appears to accumulate in depots where it should not, infiltrating normal tissues such as muscle and pancreas [3] . Bone marrow is no exception since fat content increases within this haematopoietic and osteogenic tissue, making it an ectopic fat depot in older aged individuals [1, 4, 5] .
Introduction
The redistribution of body fat is a prevalent feature of the aging process [1, 2] . With aging, body fat appears to accumulate in depots where it should not, infiltrating normal tissues such as muscle and pancreas [3] . Bone marrow is no exception since fat content increases within this haematopoietic and osteogenic tissue, making it an ectopic fat depot in older aged individuals [1, 4, 5] .
Various theories have been proposed for the role and the cause of the increased bone marrow fat [4] [5] [6] . It has been proposed that the conversion of osteoblast progenitors into adipocyte-like cells accounts for the increased bone marrow fat at the expense of bone forming cells [4, 5] . It has also been suggested that an inverse relationship exists in the marrow cavity between bone and fat where fat would occupy the space left empty by age-related bone loss or altered haematopoietic capacity [7, 8] .
The accumulation of reactive lipids in metabolically active tissues such as pancreatic islets, liver, heart and skeletal muscle leads to lipotoxicity [3, 9] . Lipotoxicity has been shown to contribute to the pathophysiology of insulin resistance, type 2 diabetes, steatotic liver disease and heart failure [3, 9] . In the case of aging bone marrow, similar lipotoxity could impact mature osteoblasts negatively due to their close proximity to marrow adipocytes [10] .
In fact, there is evidence suggesting that bone marrow fat plays a toxic role similar to that seen in other organs, resulting in the further loss of mature osteoblasts. In vitro studies have found that co-culture of osteoblasts with adipocytes results in a decrease of osteoblasts proliferation [11] . A further study has [15] .
Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro

Materials and methods
Normal human osteoblasts (NHOst)
NHOst
Oil red O staining and its quantification
To demonstrate adipogenesis, oil red O staining was used as previously described [16] . 
Cerulenin treatment
Human differentiating pre-adipocytes were plated in co-culture as previously described [14, 15] 
Determination of cell proliferation
To determine the effect of cerulenin on adipocyte proliferation, differentiating pre-adipocytes were plated in 96-well plates at a density of 1ϫ10 4 
Determination of osteoblast function
As previously reported [17] 
Treatment of osteoblasts with FA
After identification of the predominant FA in our model, NHOst were plated and treated with either stearate or palmitate at normal physiological concentrations employed in other published cell models [20, 21] . A FA known to stimulate osteoblast function (linolate) was used as control at a dose previously used in other study [22, 23] 
Results
Effect of inhibition of FA synthase on adipocytes differentiation in co-cultures
The initial studies evaluated the effect of the FA synthase inhibitor cerulenin on NHOst adipogenesis. As shown in Fig. 1A ( (Fig. 1B) .
upper panels), neither the presence of osteoblasts nor the addition of cerulenin to the adipogenic medium affected the preadipocytes' capacity to differentiate and produce fat droplets. Quantification of oil red O and protein expression levels of PPAR-␥ showed no differences between cerulenin treated versus untreated differentiating adipocytes (data not shown). In addition, treatment with cerulenin did not show any effect on preadipocytes proliferation
Inhibition of FA synthase prevents the inhibitory effect of adipocytes on osteoblast function
NHOst were plated in co-culture with human pre-adipocytes induced to undergo adipogenesis in the absence or presence of the FA synthase inhibitor cerulenin or vehicle alone. After 3 weeks in co-culture, osteoblasts were stained with ALP and alizarin red to identify function and mineralization respectively. As shown in Fig. 1A and C, both osteoblast function and mineralization were significantly inhibited by the presence of adipocytes in the co-culture. This inhibitory effect was prevented by addition of cerulenin to the media (P Ͻ 0.001). Whereas addition of 2.5 nM of cerulenin showed no effect on osteoblast function (data not shown), both 5 and 10 nM cerulenin showed a similar inhibitory effect on adipocyte toxicity. Furthermore, expression of Runx2 and OCN was significantly reduced by the presence of adipocytes in the apical side of the co-cultures (Fig. 1D and E) (P Ͻ 0.001). Finally, this reduction in Runx2, OSX and OCN expression was prevented by addition of cerulenin (10 nM) to the media in the AD/OB condition (P Ͻ 0.001).
Inhibition of FA synthase prevents the inhibitory effect of adipocytes on osteoblast proliferation
Supernatants were collected from the osteoblast side of the membrane in the six different conditions (AD/OB, OB/AD, -/OB with and without cerulenin). NHOst were cultured for 24 hrs in 96-well plates. At 24 hrs, media were replaced with the respective conditioned media and cell proliferation was measured at timed intervals (24-96 hrs) as previously described [18]. Cell proliferation was significantly decreased in osteoblasts cultured with the supernatant from the AD/OB condition in the absence of cerulenin after 48, 72
and 96 hrs in culture (P Ͻ 0.001) (Fig. 2A) . In contrast, osteoblasts exposed to supernatants from all other conditions either treated or untreated with cerulenin (5 and 10 nM) showed a progressive increase in cell proliferation at all timed intervals ( Fig. 2A) .
Inhibition of FA synthase prevents osteoblast apoptosis induced by adipocyte-secreted factors
NHOst were cultured in 2-well slides for 24 hrs. After 24 hrs, media were replaced with conditioned media obtained from normal confluent differentiated human adipocytes treated with either cerulenin (10 nM) or vehicle alone. After 72 hrs in culture, media
Fig. 1 (A-C) Mature human osteoblasts were plated in co-culture with differentiating human adipocytes (AD) treated with either cerulenin (10 nM) or vehicle alone. After 3 weeks in co-culture, adipocytes were stained with oil red O (A, upper panels) to identify fat droplets and osteoblasts were stained with alkaline phosphatase (ALP) (A, lower panels) and alizarin red (C) to identify function and mineralization respectively. Addition of cerulenin to the adipocytes media did not affect adipocytes' proliferation (B) and capacity to produce fat droplets (A, upper panels). In contrast, both osteoblast function and mineralization were significantly affected by the presence of adipocytes on top of the membrane. This inhibitory effect was prevented by addition of cerulenin (10 nM) to the media (P Ͻ 0.001). (D, E) Expression levels of Runx2, osterix (OSX) and osteocalcin (OCN) quantified by Western blot analysis were significantly reduced by the presence of adipocytes (*P Ͻ 0.001) and recovered by addition of cerulenin to the media. The data are representative of three different experiments.
were removed and the number of apoptotic cells was quantified using TUNEL assay. As shown in Fig. 2B-F (Fig. 3) (Fig. 3, P Ͻ 0.001) . Furthermore, the levels of these two FA were significantly reduced to basal levels after treatment with cerulenin in the AD/OB condition ( Fig. 3, P Ͻ 0.001 ). 
Identification of changes in FA after treatment with cerulenin
Supernatants were collected from the both sides of the membrane in the six different conditions (AD/OB, OB/AD, -/OB with and without cerulenin). GC/MS analysis of all supernatants identified the presence of seven FA
Fig. 2 (A) Cerulenin prevents the inhibitory effect of adipocytes on osteoblasts survival -Supernatants were collected from the osteoblasts side of the membrane in the six different conditions (AD/OB, OB/AD, -/OB with and without cerulenin). Human osteoblasts were cultured for 24 hrs in 96-well plates. At 24 hrs, media were replaced with the supernatants and cell proliferation was measured at timed intervals (24-96 hrs). Cell proliferation was significantly decreased in osteoblasts cultured
Stearate and palmitate affect osteoblasts function and survival
As shown in Fig. 4 , osteoblasts treated with stearate and palmitate, the predominant FA found in the supernatants, showed a significant and dose-dependent reduction in function (ALP) (Fig. 4A) and mineralization (alizarin red) (Fig. 4A and B (Fig. 4A and B, P Ͻ 0.01) . Furthermore, the inhibitory effect on mineralization was potentiated by combination of both palmitate and stearate FA in the media (Fig. 4B) (Fig. 4C, P Ͻ 0.01 ).
) as compared with both untreated and linolate-treated cells (P Ͻ 0.01). Lower concentrations of palmitate and stearate showed minimal toxicity (data not shown). Additionally, linolate-treated osteoblast showed higher function and mineralization than untreated osteoblasts
Runx2 transcriptional activity in osteoblasts is affected by the presence of adipocyte-secreted factors
We tested the effect of all lipotoxic conditions on Runx2 nuclear complex binding. As shown in Fig. 5 [25] , the action that we observed after addition of cerulenin into the media was simply a reduction of the adipogenic process due to the inhibition of adipogenesis. We found that adipogenesis, cell proliferation and production of fat droplets were not affected by the presence of cerulenin at low doses whereas it was able to inhibit the synthesis of FA by differentiating adipocytes.
Furthermore, we found that in agreement with previous studies [11] [26] and type II diabetes mellitus [27] . The common apoptotic pathways activated by the presence of ectopic fat include the activation of caspase 3/7 and ceramide [26, 28] . In the case of bone, osteoblast apoptosis plays an important role in the pathophysiology of agerelated bone loss [29] . However [26] , beta cells [27] and osteoblasts [30] , but also in the particular case of palmitate, it has been reported as one of the most prevalent FA secreted into the bone marrow [31] as well as a potent inducer of apoptosis in osteoblasts [20] . In agreement with previous studies looking at lipotoxicity in other cell models [20, 26] 
